Clinical Trial: A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

Sponsor and Collaborators
M.D. Anderson Cancer Center

Contact
Contact: Michael M. Frumovitz, MD
713-792-9599


Continue Reading

Principal Investigator
Michael M. Frumovitz, MD UT MD Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT00813007